Skip to main content
Premium Trial:

Request an Annual Quote

Sequenom Sells MassArrays to South Korean Cancer Center, Two Other Customers

NEW YORK (GenomeWeb News) — Sequenom sold three of its MassArray analyzers in South Korea in the fourth quarter of 2006, the company said today.
 
The sales were made through Bioneer, a Daejeon-based genomics research products and services company that signed an exclusive deal with Sequenom in September 2006 to market and distribute the MassArray in South Korea.  
 
Sequenom said Bioneer sold one of its analysis systems to National Cancer Center of the Republic of Korea, but did not disclose the two other customers.
 
Bioneer president and CEO Han-Oh Park said the fourth-quarter sales “represent increased demand we are seeing in South Korea for fine mapping genetic analysis solutions, and for life sciences research tools in general.”
The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more